vs
Side-by-side financial comparison of Evolv Technologies Holdings, Inc. (EVLV) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $38.5M, roughly 2.0× Evolv Technologies Holdings, Inc.). On growth, Evolv Technologies Holdings, Inc. posted the faster year-over-year revenue change (32.3% vs 27.7%). Over the past eight quarters, Evolv Technologies Holdings, Inc.'s revenue compounded faster (31.8% CAGR vs 31.3%).
Sentient Technologies was an American artificial intelligence technology company based in San Francisco. Sentient was founded in 2007 and received over $143 million in funding at different points after its inception. As of 2016, Sentient was the world's most well-funded AI company. It focused on e-commerce, online content and trading.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
EVLV vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $38.5M | $75.5M |
| Net Profit | $10.9M | — |
| Gross Margin | 48.4% | 69.3% |
| Operating Margin | -20.7% | 22.7% |
| Net Margin | 28.3% | — |
| Revenue YoY | 32.3% | 27.7% |
| Net Profit YoY | 169.2% | — |
| EPS (diluted) | $0.07 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $38.5M | $75.5M | ||
| Q3 25 | $42.9M | $54.5M | ||
| Q2 25 | $32.5M | $52.4M | ||
| Q1 25 | $32.0M | $46.0M | ||
| Q4 24 | $29.1M | $59.1M | ||
| Q3 24 | $27.4M | $80.5M | ||
| Q2 24 | $25.2M | $47.1M | ||
| Q1 24 | $22.2M | $43.8M |
| Q4 25 | $10.9M | — | ||
| Q3 25 | $-1.8M | $8.8M | ||
| Q2 25 | $-40.5M | $5.9M | ||
| Q1 25 | $-1.7M | $3.0M | ||
| Q4 24 | $-15.7M | — | ||
| Q3 24 | $-30.4M | $20.3M | ||
| Q2 24 | $3.4M | $-4.5M | ||
| Q1 24 | $-11.3M | $-4.8M |
| Q4 25 | 48.4% | 69.3% | ||
| Q3 25 | 49.7% | 77.7% | ||
| Q2 25 | 49.8% | 76.5% | ||
| Q1 25 | 59.8% | 77.1% | ||
| Q4 24 | 57.5% | 76.4% | ||
| Q3 24 | 57.8% | 63.9% | ||
| Q2 24 | 58.5% | 77.4% | ||
| Q1 24 | 54.8% | 75.5% |
| Q4 25 | -20.7% | 22.7% | ||
| Q3 25 | -20.1% | 17.6% | ||
| Q2 25 | -53.8% | 12.7% | ||
| Q1 25 | -45.0% | 8.7% | ||
| Q4 24 | -64.9% | 22.6% | ||
| Q3 24 | -70.0% | 27.4% | ||
| Q2 24 | -88.7% | -4.6% | ||
| Q1 24 | -98.8% | -5.3% |
| Q4 25 | 28.3% | — | ||
| Q3 25 | -4.2% | 16.2% | ||
| Q2 25 | -124.6% | 11.2% | ||
| Q1 25 | -5.3% | 6.5% | ||
| Q4 24 | -54.0% | — | ||
| Q3 24 | -111.3% | 25.2% | ||
| Q2 24 | 13.6% | -9.6% | ||
| Q1 24 | -50.8% | -11.0% |
| Q4 25 | $0.07 | $0.26 | ||
| Q3 25 | $-0.01 | $0.17 | ||
| Q2 25 | $-0.25 | $0.12 | ||
| Q1 25 | $-0.01 | $0.06 | ||
| Q4 24 | $-0.10 | $0.40 | ||
| Q3 24 | $-0.19 | $0.41 | ||
| Q2 24 | $0.02 | $-0.09 | ||
| Q1 24 | $-0.07 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $49.1M | $97.5M |
| Total DebtLower is stronger | $28.6M | $22.7M |
| Stockholders' EquityBook value | $119.4M | $130.3M |
| Total Assets | $304.4M | $216.3M |
| Debt / EquityLower = less leverage | 0.24× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $49.1M | $97.5M | ||
| Q3 25 | $56.2M | $94.4M | ||
| Q2 25 | $36.9M | $96.0M | ||
| Q1 25 | $35.0M | $93.2M | ||
| Q4 24 | $51.9M | $101.0M | ||
| Q3 24 | $56.0M | $96.7M | ||
| Q2 24 | $56.5M | $96.8M | ||
| Q1 24 | $81.0M | $107.2M |
| Q4 25 | $28.6M | $22.7M | ||
| Q3 25 | $28.5M | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $0 | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $119.4M | $130.3M | ||
| Q3 25 | $102.2M | $115.3M | ||
| Q2 25 | $92.7M | $104.7M | ||
| Q1 25 | $121.1M | $97.1M | ||
| Q4 24 | $117.7M | $92.1M | ||
| Q3 24 | $129.0M | $71.1M | ||
| Q2 24 | $151.2M | $48.5M | ||
| Q1 24 | $139.8M | $51.0M |
| Q4 25 | $304.4M | $216.3M | ||
| Q3 25 | $304.3M | $202.9M | ||
| Q2 25 | $280.4M | $194.9M | ||
| Q1 25 | $256.0M | $196.2M | ||
| Q4 24 | $268.1M | $213.3M | ||
| Q3 24 | $278.5M | $220.7M | ||
| Q2 24 | $269.1M | $205.0M | ||
| Q1 24 | $280.0M | $214.1M |
| Q4 25 | 0.24× | 0.17× | ||
| Q3 25 | 0.28× | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 0.00× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $15.6M | $14.4M |
| Free Cash FlowOCF − Capex | — | $14.4M |
| FCF MarginFCF / Revenue | — | 19.1% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 1.43× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.6M | $14.4M | ||
| Q3 25 | $3.5M | $9.7M | ||
| Q2 25 | $2.1M | $14.1M | ||
| Q1 25 | $-2.5M | $3.6M | ||
| Q4 24 | $3.2M | $15.6M | ||
| Q3 24 | $3.7M | $11.0M | ||
| Q2 24 | $-21.6M | $1.0M | ||
| Q1 24 | $-16.2M | $11.2M |
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
| Q4 25 | 1.43× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | -6.31× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
